DOP2006000089A - Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios. - Google Patents

Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios.

Info

Publication number
DOP2006000089A
DOP2006000089A DO2006000089A DO2006000089A DOP2006000089A DO P2006000089 A DOP2006000089 A DO P2006000089A DO 2006000089 A DO2006000089 A DO 2006000089A DO 2006000089 A DO2006000089 A DO 2006000089A DO P2006000089 A DOP2006000089 A DO P2006000089A
Authority
DO
Dominican Republic
Prior art keywords
preparation
derivatives
tetrahydronaftaline
inflammatory
procedures
Prior art date
Application number
DO2006000089A
Other languages
English (en)
Inventor
Heike Schacke
Stefan Baurle
Anne Mengel
Konrad Krolikiewicz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DOP2006000089A publication Critical patent/DOP2006000089A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se relaciona con varios derivados de tetrahidronaftalina sustituidos de la formula (I), con procedimientos para su preparacion y con su use como antiinflamatorios.
DO2006000089A 2005-04-14 2006-04-17 Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios. DOP2006000089A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005017316A DE102005017316A1 (de) 2005-04-14 2005-04-14 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Publications (1)

Publication Number Publication Date
DOP2006000089A true DOP2006000089A (es) 2006-11-15

Family

ID=36889239

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000089A DOP2006000089A (es) 2005-04-14 2006-04-17 Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios.

Country Status (8)

Country Link
AR (1) AR053582A1 (es)
DE (1) DE102005017316A1 (es)
DO (1) DOP2006000089A (es)
GT (1) GT200600152A (es)
PE (1) PE20061360A1 (es)
TW (1) TW200716565A (es)
UY (1) UY29482A1 (es)
WO (1) WO2006108713A2 (es)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63220242A (ja) * 1987-03-10 1988-09-13 Fuji Photo Film Co Ltd フオトレジスト組成物
JPH02501737A (ja) * 1987-05-15 1990-06-14 シェリング・コーポレーション アリール置換ナフタリン，ベンゾオキセピン，ベンズアゼピン，ベンゾシクロヘプテン誘導体
PT87988B (pt) * 1987-07-16 1995-05-04 Byk Gulden Lomberg Chem Fab Processo para a preparacao de diazois e de composicoes farmaceuticas que os contem
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
CA2297906A1 (en) * 1997-07-22 1999-02-04 Bret Eugene Huff Pharmaceutical compounds
GB9716244D0 (en) * 1997-07-31 1997-10-08 Electrophoretics International Pharmaceutical compounds
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
US6013830A (en) * 1998-03-30 2000-01-11 Sepracor Inc. Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
AU5682299A (en) * 1998-08-21 2000-03-14 Scripps Research Institute, The Catalytic asymmetric aminohydroxylation with amino-substituted heterocycles
JP2000256255A (ja) * 1999-03-10 2000-09-19 Kuraray Co Ltd （±）−トランス−ペルメトリン酸の光学分割法
SE9903930D0 (sv) * 1999-10-29 1999-10-29 Astra Pharma Inc Novel compounds and a novel process for their preparation
ES2193839B1 (es) * 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
AU2002332541B2 (en) * 2001-09-21 2008-05-08 Eli Lilly And Company Muscarinic agonists
PE20030547A1 (es) * 2001-09-24 2003-08-18 Bayer Corp Derivados de imidazol para el tratamiento de la obesidad
ES2333586T3 (es) * 2001-11-21 2010-02-24 PHARMACIA & UPJOHN COMPANY LLC Derivados de aril 1,4-pirazina sustituidos.
US6875866B2 (en) * 2002-02-21 2005-04-05 Schering Corporation Process for synthesis of D1 receptor antagonists
KR101048559B1 (ko) * 2002-08-26 2011-07-11 메르크 파텐트 게엠베하 사이클로펜타[ｂ]나프탈렌 유도체
US7575785B2 (en) * 2003-08-22 2009-08-18 Merck Patent Gmbh Cyclopenta[a]naphthaline derivatives
CN1239441C (zh) * 2003-09-12 2006-02-01 中国科学院上海有机化学研究所 利用固载化的双辛可尼类生物碱配体催化不对称羟胺化和双羟化反应的方法

Also Published As

Publication number Publication date
WO2006108713A3 (de) 2006-12-14
WO2006108713A2 (de) 2006-10-19
PE20061360A1 (es) 2007-01-26
AR053582A1 (es) 2007-05-09
UY29482A1 (es) 2006-10-31
TW200716565A (en) 2007-05-01
DE102005017316A1 (de) 2006-10-19
GT200600152A (es) 2007-03-19

Similar Documents

Publication Publication Date Title
CR8357A (es) Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio
UY30057A1 (es) Pirimidinas sustituidas con sulfoximinas, procesos para su producción y uso de las mismas como fármacos
ECSP077271A (es) Derivados de pirimidina
DOP2011000171A (es) Compuestos organico
ECSP077259A (es) Derivados de pirimidina
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
ECSP12011654A (es) Derivados de 5-fluoropirimidinona
ECSP088740A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios
ECSP10010722A (es) Compuestos orgánicos
ECSP066540A (es) Pentanoles transpuestos, un método para prepararlos y su uso como antiinflamatorios
ECSP078055A (es) Formas sólidas cristalinas de tigeciclina y métodos para preparar las mismas
UY29434A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn
PA8644701A1 (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
UY29481A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
UY30801A1 (es) Compuestos calciliticos
CR9574A (es) Potenciadores del receptor ampa
DK1893597T3 (da) AMPA-receptorpotentiatorer
UY29435A1 (es) Derivados de 5h-benzociclohepteno, procedimientos para su preparación y su uso como antiinflamatorios.
DOP2006000089A (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios.
DOP2006000064A (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como inhibidores de la inflamacion
UY28584A1 (es) Derivados del tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorio
UY29309A1 (es) Aminoalcoholes tricíclicos, procedimientos para su preparación y su uso como inhibidores de inflamación
CU23569A3 (es) Derivados 1-amino-2-oxi sustituidos del tetrahidronaftaleno, procedimiento para su producción y su uso como antinflamatorio
UY28907A1 (es) Derivados de cromanol, un procedimiento para su preparación y su uso como inhibidores de la inflamación.